Encision Inc (ECIA)
OTHER OTC:ECIA
Want to see ECIA full AI Analyst Report?
ECIA Stock Chart & Stats
$0.14
$0.03(7.14%)
At close: 4:00 PM EST
$0.14
$0.03(7.14%)
Day’s Range― - ―
52-Week Range$0.09 - $0.42
Previous CloseN/A
Volume5.10K
Average Volume (3M)16.18K
Market Cap
$3.04M
Enterprise Value$3.96M
Total Cash (Recent Filing)$71.73K
Total Debt (Recent Filing)$1.53M
Price to Earnings (P/E)―
Beta0.16
Next Earnings
May 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding16,879,644
10 Day Avg. Volume10,380
30 Day Avg. Volume16,177
Financial Highlights & Ratios
PEG Ratio0.38
Price to Book (P/B)3.45
Price to Sales (P/S)0.87
P/FCF Ratio-42.25
Enterprise Value/Market Cap1.30
Enterprise Value/Revenue0.63
Enterprise Value/Gross Profit1.19
Enterprise Value/Ebitda-16.51
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginA roughly 53% gross margin indicates durable product-level economics that can absorb fixed costs and support profitability as revenue stabilizes. Over 2-6 months this margin resilience gives management room to focus on reducing operating expenses and improving operating leverage.
Occasional Positive Cash GenerationThe company has demonstrated the ability to generate positive operating and free cash flow in selected years, showing the business can be cash-generative under the right conditions. This suggests operational fixes could sustainably restore cash conversion over the medium term.
Deregistration Reduces Compliance BurdenVoluntary SEC deregistration is a structural decision to cut recurring compliance costs and management time. If executed as planned, lower fixed administrative costs can preserve cash and let management prioritize core operations and product development over regulatory reporting.
Bears Say
TTM Balance-sheet Red FlagZero equity and negative total assets on a TTM basis materially weaken the company’s financial cushion, increasing solvency and counterparty risks. This structural balance-sheet weakness limits borrowing capacity and heightens the chance of distress if cash flows don't recover.
Negative Trailing Cash FlowNegative TTM operating and free cash flow, plus prior periods of sizable burn, indicate inconsistent cash generation. This structural cash shortfall raises the likelihood of needing external financing or asset sales, which can dilute shareholders or constrain operations.
Declining Revenue & Persistent LossesA contracting top line paired with negative EBIT/EBITDA and a ~-6% net margin shows the core business is loss-making. Without sustained revenue growth or meaningful operating-cost reduction, the company faces structural difficulty returning to consistent profitability.
Encision News
ECIA FAQ
What was Encision Inc’s price range in the past 12 months?
Encision Inc lowest stock price was $0.09 and its highest was $0.42 in the past 12 months.
What is Encision Inc’s market cap?
Encision Inc’s market cap is $3.04M.
When is Encision Inc’s upcoming earnings report date?
Encision Inc’s upcoming earnings report date is May 14, 2026 which is in 27 days.
How were Encision Inc’s earnings last quarter?
Currently, no data Available
Is Encision Inc overvalued?
According to Wall Street analysts Encision Inc’s price is currently Overvalued.
Does Encision Inc pay dividends?
Encision Inc does not currently pay dividends.
What is Encision Inc’s EPS estimate?
Encision Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Encision Inc have?
Encision Inc has 16,879,644 shares outstanding.
What happened to Encision Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Encision Inc?
Currently, no hedge funds are holding shares in ECIA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Encision Inc
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.
Technical Analysis
Ownership Overview
52.51% Insiders
6.29% Other Institutional Investors
41.20% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---